Miguel Torralba

1.7k total citations
75 papers, 473 citations indexed

About

Miguel Torralba is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Miguel Torralba has authored 75 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 23 papers in Infectious Diseases and 19 papers in Surgery. Recurrent topics in Miguel Torralba's work include HIV/AIDS drug development and treatment (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis C virus research (9 papers). Miguel Torralba is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis C virus research (9 papers). Miguel Torralba collaborates with scholars based in Spain, United Kingdom and United States. Miguel Torralba's co-authors include Henar Calvo Sánchez, J.R. Larrubia, E. Sanz‐de‐Villalobos, Federico Pulido, Manuel Rodríguez Zapata, Rafael Rubio, Alicia Lorenzo, José M. Gatell, José Ramón Arribas and Concepción Cepeda and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Miguel Torralba

63 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miguel Torralba Spain 12 135 135 118 70 68 75 473
Cristina Mazzali Italy 14 152 1.1× 103 0.8× 355 3.0× 70 1.0× 22 0.3× 26 715
Christopher W. James United States 11 49 0.4× 181 1.3× 213 1.8× 43 0.6× 88 1.3× 31 485
Όλγα Κατσαρού Greece 17 70 0.5× 179 1.3× 115 1.0× 26 0.4× 156 2.3× 45 782
Susan H. Gawel United States 9 107 0.8× 92 0.7× 81 0.7× 15 0.2× 28 0.4× 25 386
Robert Dressler United States 12 98 0.7× 102 0.8× 90 0.8× 30 0.4× 28 0.4× 20 465
Shikha Mehta United States 13 112 0.8× 335 2.5× 159 1.3× 70 1.0× 48 0.7× 30 702
Isabel Galán Spain 11 46 0.3× 79 0.6× 56 0.5× 46 0.7× 98 1.4× 33 303
Moisés A. Huamán United States 15 173 1.3× 368 2.7× 290 2.5× 56 0.8× 25 0.4× 58 631
Emanuela Foglia Italy 13 87 0.6× 69 0.5× 73 0.6× 34 0.5× 17 0.3× 79 429
Davide Croce Italy 12 58 0.4× 114 0.8× 110 0.9× 16 0.2× 37 0.5× 65 496

Countries citing papers authored by Miguel Torralba

Since Specialization
Citations

This map shows the geographic impact of Miguel Torralba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Torralba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Torralba more than expected).

Fields of papers citing papers by Miguel Torralba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Torralba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Torralba. The network helps show where Miguel Torralba may publish in the future.

Co-authorship network of co-authors of Miguel Torralba

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Torralba. A scholar is included among the top collaborators of Miguel Torralba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Torralba. Miguel Torralba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castro, Antonio Arjona, Carlos Rubio-Terrés, Darío Rubio-Rodríguez, et al.. (2024). HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review. PubMed. 26(2). 67–79. 2 indexed citations
2.
Torralba, Miguel, et al.. (2024). Prognostic Impact of Metabolic Syndrome and Steatotic Liver Disease in Hepatocellular Carcinoma Using Machine Learning Techniques. Metabolites. 14(6). 305–305. 1 indexed citations
3.
4.
Torralba, Miguel, et al.. (2024). Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma. International Journal of Molecular Sciences. 25(4). 1996–1996. 5 indexed citations
5.
Pekarek, Leonel, et al.. (2024). Glycemic Risk Index in a Cohort of Patients with Type 1 Diabetes Mellitus Stratified by the Coefficient of Variation: A Real-Life Study. Diabetes Technology & Therapeutics. 26(12). 960–967. 2 indexed citations
6.
7.
8.
9.
Sanz‐de‐Villalobos, E., et al.. (2023). IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection. iScience. 27(1). 108666–108666. 2 indexed citations
10.
Brañas, Fátima, Miguel Torralba, Antonio Antela, et al.. (2023). Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV. BMC Geriatrics. 23(1). 4–4. 19 indexed citations
11.
Sánchez, Henar Calvo, et al.. (2022). Model to predict on‐treatment restoration of functional HBV‐specific CD8+ cell response foresees off‐treatment HBV control in eAg‐negative chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 55(12). 1545–1559. 10 indexed citations
12.
Cabello, Alfonso, Luz Martı́n-Carbonero, Jesús Sanz, et al.. (2022). 48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort. PLoS ONE. 17(11). e0277606–e0277606. 10 indexed citations
13.
Sánchez, Henar Calvo, et al.. (2021). Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C. Cells. 10(3). 538–538. 4 indexed citations
14.
Sánchez, Henar Calvo, et al.. (2021). Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma. Cancers. 13(8). 1922–1922. 44 indexed citations
15.
Pérez‐Tanoira, Ramón, Lourdes Lledó, Miguel Torralba, et al.. (2021). High Seroprevalence Against SARS-CoV-2 Among Faculty of Medicine and Health Sciences Personnel and Students of the University of Alcalá, Spain: Contributing Factors. International Journal of General Medicine. Volume 14. 7017–7024. 2 indexed citations
16.
Torralba, Miguel, et al.. (2018). Evolución clínica de una cohorte de pacientes con diabetes mellitus tipo 2 tras su valoración en endocrinología. Estudio a 26 semanas. Endocrinología Diabetes y Nutrición. 65(4). 220–228. 2 indexed citations
17.
Torralba, Miguel, et al.. (2017). Exposición a radiación diagnóstica en pacientes con enfermedad de Crohn: estudio retrospectivo en un hospital medio y sus factores predictivos. Gastroenterología y Hepatología. 41(2). 97–102. 1 indexed citations
18.
19.
Tena, Daniel, et al.. (2012). Meningitis caused by Abiotrophia defectiva: case report and literature review. Infection. 41(2). 571–574. 11 indexed citations
20.
Torralba, Miguel, et al.. (2008). Evaluación del uso de los inhibidores de la bomba de protones en un servicio de medicina interna. Revista Española de Enfermedades Digestivas. 100(2). 76–81. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Mazzali Breakdown of academic impact, for papers by Christopher W. James Breakdown of academic impact, for papers by Όλγα Κατσαρού Breakdown of academic impact, for papers by Susan H. Gawel Breakdown of academic impact, for papers by Robert Dressler Breakdown of academic impact, for papers by Shikha Mehta Breakdown of academic impact, for papers by Isabel Galán Breakdown of academic impact, for papers by Moisés A. Huamán Breakdown of academic impact, for papers by Emanuela Foglia Breakdown of academic impact, for papers by Davide Croce
Rankless by CCL
2026